Yield of Gluten Challenge in Patients on Self-Prescribed Gluten-Free Diets
Digestive Diseases and Sciences · 2024
DOI: 10.1007/s10620-024-08399-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2024. Verfasst von Martin Ventoso und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, New York, USA. mav9217@nyp.org. Hauptthemen laut MEDLINE: Celiac Disease, Diet, Gluten-Free, Duodenum, Glutens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Patients on a gluten-free diet (GFD) whose celiac disease (CD) status is unknown may undergo gluten challenge (GC) to clarify their diagnosis. Though this is an established diagnostic practice, the proportion of patients undergoing GC who are diagnosed with CD is unknown. AIMS: We aimed to analyze which factors were predictive of having CD in a cohort of patients who underwent GC followed by upper endoscopy with duodenal biopsy. METHODS: We identified adult patients at a CD referral center who had been on a GFD and then underwent GC to determine a diagnosis of CD during the years spanning 2006 to 2020. We compared those patients found to have CD (defined as villus atrophy/Marsh 3) on duodenal biopsy with those who did not, using the chi square and Fischer exact tests. RESULTS: We identified 206 patients who underwent GC. Of these 206, 30 (14%) were diagnosed with CD based on post-GC duodenal biopsy. 176 of the 206 (85%) patients reported various gastrointestinal symptoms, including bloating (39%), though these were more common in those without CD (any GI symptoms: 89% vs 67%, p 0.004; bloating: 43% vs 20%, p 0.019). Serology values, when normalized, including pre- and post-challenge TTG IgA (37% vs 1.7%, p 0.001; 23% versus 2.3%, p 0.001), DGP IgG and IgA (57% vs 2.8%, p 0.001; 37% vs 6.2%, p 0.001) were higher in the group of patients with CD. CONCLUSION: Among patients undergoing GC for diagnostic purposes, only 14% had evidence of villus atrophy corresponding with CD on duodenal biopsy. The presence of any elevated pre-challenge serology was associated with CD. Bloating in combination with low serologies may help risk stratify patients as being less likely to have CD upon GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, New York, USA. mav9217@nyp.org.
- Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, 622 West 168th Street, Room 205, New York, NY, 10032, USA. mav9217@nyp.org.
- Department of Medicine, Jefferson Health, Philadelphia, PA, USA.
- Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, New York, USA.
- Department of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, USA.
Zitieren
APA
Ventoso, M., Ignatiev, J. H., Shin, S., Krishnareddy, S., Lewis, S., Green, P. H. R., & Lebwohl, B. (2024). Yield of Gluten Challenge in Patients on Self-Prescribed Gluten-Free Diets. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08399-5
Vancouver
Ventoso M, Ignatiev JH, Shin S, Krishnareddy S, Lewis S, Green PHR, et al. Yield of Gluten Challenge in Patients on Self-Prescribed Gluten-Free Diets. Digestive Diseases and Sciences. 2024. doi:10.1007/s10620-024-08399-5
BibTeX
@article{Ventoso2024,
author = {Ventoso, Martin and Ignatiev, John Henry and Shin, Seokyu and Krishnareddy, Suneeta and Lewis, Suzanne and Green, Peter H R and Lebwohl, Benjamin},
title = {Yield of Gluten Challenge in Patients on Self-Prescribed Gluten-Free Diets},
journal = {Digestive Diseases and Sciences},
year = {2024},
doi = {10.1007/s10620-024-08399-5}
}
EUVIMED